Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4269/ajtmh.20-0912 http://scihub22266oqcxt.onion/10.4269/ajtmh.20-0912 34242180!8592361!34242180     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Trop+Med+Hyg 2021 ; 105 (3): 745-750 Nephropedia Template TP {{tp|p=34242180|t=2021. Differentiating Dengue from COVID-19: Comparison of Cases in Colombia |pdf=|usr=}}{{34242180}} gab.com Text Differentiating Dengue from COVID-19: Comparison of Cases in Colombia JO: Am J Trop Med Hyg http://www.kidney.de/pget.php?&tw=1&pmid=34242180 #FOAvip The differentiation between dengue and COVID-19 diagnoses is a challenge in tropical regions because of the similarity of symptoms and limited access to specific diagnostic tests for each disease. The objective of this study was to describe the initial symptoms and laboratory test values of patients who presented to the emergency department with dengue or COVID-19. A cross-sectional study was performed in a single center in Cali, Colombia. The inclusion criteria were patients with a diagnosis of dengue or COVID-19 who were older than 14 years of age. All patients experienced fever or other symptoms for fewer than 10 days. Linear regression was performed to evaluate the differences in the neutrophil-lymphocyte ratio (NLR) between patients diagnosed with COVID-19 and dengue, and was adjusted for sex and age group (</= 31 and > 31 years). The sample size was calculated to test the hypothesis that the median NLR in COVID-19 patients is higher than that in dengue patients. A P value < 0.05 was considered statistically significant for all analyses. A total of 93 patients were included: 70 with dengue and 23 with COVID-19. Dengue patients were younger than COVID-19 patients. There were significant differences between dengue and COVID-19 patients regarding platelet count (P < 0.01), neutrophil count (P < 0.01), NLR (P < 0.01), and abnormal alanine transaminase (ALT) (P = 0.03). The NLR was significantly higher in COVID-19 patients than in dengue patients (P < 0.01). In conclusion, during the first week of symptoms, absolute neutrophil count, NLR, and platelet count could help guide the initial differential approach between dengue and COVID-19. These findings could be useful in geographical areas with a lack of resources. Twit Text FOAVip Differentiating Dengue from COVID-19: Comparison of Cases in Colombia ????Am J Trop Med Hyg http://www.kidney.de/pget.php?&tw=1&pmid=34242180 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34242180 #FOAvip English Wikipedia <ref>{{Cite pmid|34242180}}</ref> Differentiating Dengue from COVID-19: Comparison of Cases in Colombia #MMPMID34242180 Rosso F; Parra-Lara LG; Agudelo-Rojas OL; Martinez-Ruiz DM Am J Trop Med Hyg 2021[Jul]; 105 (3): 745-750 PMID34242180show ga The differentiation between dengue and COVID-19 diagnoses is a challenge in tropical regions because of the similarity of symptoms and limited access to specific diagnostic tests for each disease. The objective of this study was to describe the initial symptoms and laboratory test values of patients who presented to the emergency department with dengue or COVID-19. A cross-sectional study was performed in a single center in Cali, Colombia. The inclusion criteria were patients with a diagnosis of dengue or COVID-19 who were older than 14 years of age. All patients experienced fever or other symptoms for fewer than 10 days. Linear regression was performed to evaluate the differences in the neutrophil-lymphocyte ratio (NLR) between patients diagnosed with COVID-19 and dengue, and was adjusted for sex and age group ( 31 years). The sample size was calculated to test the hypothesis that the median NLR in COVID-19 patients is higher than that in dengue patients. A P value < 0.05 was considered statistically significant for all analyses. A total of 93 patients were included: 70 with dengue and 23 with COVID-19. Dengue patients were younger than COVID-19 patients. There were significant differences between dengue and COVID-19 patients regarding platelet count (P < 0.01), neutrophil count (P < 0.01), NLR (P < 0.01), and abnormal alanine transaminase (ALT) (P = 0.03). The NLR was significantly higher in COVID-19 patients than in dengue patients (P < 0.01). In conclusion, during the first week of symptoms, absolute neutrophil count, NLR, and platelet count could help guide the initial differential approach between dengue and COVID-19. These findings could be useful in geographical areas with a lack of resources. |*SARS-CoV-2[MESH] |Adolescent[MESH] |Adult[MESH] |COVID-19/blood/*diagnosis[MESH] |Cross-Sectional Studies[MESH] |Dengue/blood/*diagnosis[MESH] |Diagnosis, Differential[MESH] |Female[MESH] |Humans[MESH] |Lymphocytes[MESH] |Male[MESH] |Middle Aged[MESH] |Neutrophils[MESH]Differentiating Dengue from COVID-19: Comparison of Cases in Colombia (epmc).pdf DeepDyve Pubget Overpricing